Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: thecleanser

thecleanser

posted on Sep 11, 2008 01:21PM

To mitigate the "We want our share of the Core Portfolio" nonsense on the other board.



6.2 Retention of Rights; No Action With Respect to the MSD Patents.
Patriot and TPL shall retain all of their respective rights with respect to the
MSD Patents, except those rights to the MSD Patents transferred by Patriot and
TPL to P-Newco pursuant to the Newco Licenses and the Merger Agreement
. From the
date hereof until the termination of the Commercialization Agreement, neither
Patriot nor any of its Representatives shall take any action with respect to
those matters concerning which TPL is authorized to act on behalf of the parties
pursuant to the Commercialization Agreement and the Grant referred to therein,
including, but not limited to, contacting, pursuing litigation against, or
entering into discussions or negotiations with potential infringers, entering
into license agreements, settlement agreements, or other similar agreements with
respect to the MSD Patents, or selling or otherwise transferring any interest in
the MSD Patents. Notwithstanding the foregoing, subject to Section 7.7, Patriot
shall be entitled to take all actions contemplated by Section 7.1 of this
Agreement. From the termination of the Commercialization Agreement until one
year from the date thereof, Patriot shall not contact or enter into discussions
or negotiations with, or enter into license agreements, settlement agreements,
or other similar agreements with respect to the MSD Patents, or pursue any
litigation or other dispute resolution involving claims related to the MSD
Patents with regard to any potential licensee with whom TPL is engaged in active
negotiations at the time of the termination of the Commercialization Agreement
and identified in writing by TPL within five (5) days after such termination
("Active Potential Licensees").

http://sec.edgar-online.com/2005/06/...





Be well

Share
New Message
Please login to post a reply